SGS Bolsters North American Food Safety Footprint with Murray-Brown Laboratories Acquisition
Event summary
- SGS acquired Murray-Brown Laboratories, a Denver-based food testing laboratory, on February 12, 2026.
- Murray-Brown Laboratories specializes in microbial and analytical chemistry testing, including pesticide and mycotoxin detection.
- The acquisition expands SGS’s geographic footprint and analytical capabilities, particularly in microbiological testing and nutraceutical testing (kratom, kava, hemp).
- SGS aims to double North American sales by 2027 through initiatives like this, as part of its 'Strategy 27'.
The big picture
The acquisition underscores the growing importance of food safety and quality assurance in North America, driven by stricter regulations, heightened consumer awareness, and the increasing complexity of global supply chains. SGS, already a dominant player in the TIC sector, is strategically expanding its North American presence to capitalize on this trend and achieve its ambitious revenue growth targets. The move also highlights the increasing demand for specialized testing services, particularly in the nutraceutical space, which is facing heightened regulatory and consumer scrutiny.
What we're watching
- Regulatory Headwinds
- Increased FDA and USDA scrutiny, coupled with rising foodborne illness rates, will likely continue to drive demand for advanced testing services, putting pressure on margins and requiring ongoing investment in technology and compliance.
- Integration Risk
- The success of this acquisition hinges on SGS’s ability to effectively integrate Murray-Brown Laboratories’ operations and expertise, avoiding disruption to existing client relationships and maintaining quality standards.
- Market Dynamics
- The pace at which SGS can leverage Murray-Brown’s specialized testing capabilities (kratom, kava, hemp) will determine its ability to capture a larger share of the rapidly evolving nutraceutical market.
Related topics